SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001607062-15-000342
Filing Date
2015-08-04
Accepted
2015-08-04 15:58:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 gnbt80415form424b3.htm 424B3 1811724
  Complete submission text file 0001607062-15-000342.txt   1812722
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 424B3 | Act: 33 | File No.: 333-205724 | Film No.: 151025397
SIC: 2834 Pharmaceutical Preparations